✦ LIBER ✦

39: Epoetin Alfa Dosing Trend Over Time in Adult Patients With Chronic Kidney Disease: A Medical Benefit Perspective

✍ Scribed by Robert A. Bailey; François Laliberté; Marie-Hélène Lafeuille; Mekré Senbetta; R. Scott McKenzie; Katherine Dea; Francis Vekeman

Book ID: 114469605
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 94 KB
Volume: 55
Category: Article
ISSN: 0272-6386
DOI: 10.1053/j.ajkd.2010.02.046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

37: Dosing Trends Over Time of Epoetin A

37: Dosing Trends Over Time of Epoetin Alfa Utilization in Chronic Kidney Disease Patients Not on Dialysis:APharmacy Benefit Perspective

✍ Robert A. Bailey; François Laliberté; Francis Vekeman; Mekré Senbetta; R. Scott 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Hemoglobin Variability with Extended Dos

Hemoglobin Variability with Extended Dosing of Epoetin Alfa in Patients with Chronic Kidney Disease and Not on Dialysis

✍ Robert A. Bailey; Tracy McGowan; K. Linda Tang; Wayne K. Langholff; Keith C. Lan 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 136 KB 👁 2 views

133: Hematologic Outcomes and Dosing Pat

133: Hematologic Outcomes and Dosing Patterns in Anemic Patients With Pre-Dialysis Chronic Kidney Disease (CKD) Switching From Darbepoetin Alfa (DARB) to Epoetin Alfa (EPO)

✍ Claudia Hura; James Jackson; Orsolya Lunacsek; Robert A. Bailey; R. Scott McKenz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 98 KB